Clinical characterization of Dicea a new cellulose membrane for haemodialysis

Clinical Nephrology

Volumn 48, Issue 4, 1997, Pages 253-259

  Hoenich, N A ^a   Woffindin, C ^a   Cox, P J ^a   Goldfinch, M ^b   Roberts, S J ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

2 microglobulin removal; Biocompatibility; Cellulose membranes; Hemodialysis; Polysulfone membranes

Indexed keywords

BETA 2 MICROGLOBULIN; CELLULOSE; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; DIALYSIS FLUID; POLYSULFONE;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; LEUKOCYTE COUNT; MEMBRANE PERMEABILITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BETA 2-MICROGLOBULIN; BIOCOMPATIBLE MATERIALS; CELLULOSE; COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATININE; HEMODIALYSIS SOLUTIONS; HUMANS; LEUKOCYTE COUNT; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PHOSPHATES; PLATELET COUNT; POLYMERS; PROSPECTIVE STUDIES; PROTEINS; RENAL DIALYSIS; SERUM ALBUMIN; SULFONES; UREA;

EID: 0030729891     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Akizawa T, Kitaoka T, Koshikawa S, Watanabe T, Imamura K et al. 1986 Development of a regenerated cellulose non complement activating membrane for hemodialysis. Trans Am Soc Artif Intern Organs 32: 76-80
2. Baker RJ, Nelder NA 1978 Generalized Linear Interactive Modelling Numerical Algorithms Group Oxford
3. 2 microglobulin concentration after cuprophane haemodialysis. Lancet 1: 628-629
4. Bhakdi S, Fassbender W, Hugo F, Carreno MP, Berstecher C, Malasit P, Kazatchkine MD 1988 Relative inefficiency of terminal complement activation. J Immunol 141: 3117-3122
5. Brachtendorf TH, Nederlof B 1994 Fresenius polysulfone - the "gold standard" in dialysis 10 years of experience. Clinical Nephrology 42 (Suppl 1): S3-S12
6. Cheung AK, Parker CJ, Wilcox L, Janatova J 1989 Activation of the alternate pathway of complement by hemodialysis membranes. Kidney International 36: 257-265
7. 2 integrins are required for neutrophil degranulation induced by hemodialysis. Kidney International 40: 649-660
8. Colton CK 1987 Analysis of the membrane processes for blood purification. Blood Purification 5: 202-251
9. Deppisch R, Schmidtt V, Bommer J, Hansch G, Ritz E, Rauterberg E 1990 Fluid phase generation of a terminal complement complex as a novel index of biocompatibility. Kidney International 37: 696-706
10. Hoenich NA, Appleton D, Cox PJ, Woffindin C 1995 Application of a Standard method to characterise clearance blood flowrelationships in hemodialysis. Artificial Organs 19: 1136-1142
11. Hoenich NA, Woffindin C, Brennan A, Cox PJ, Matthews JNS, Goldfinch ME 1996 A comparison of three brands of polysulfone membranes. J Amer Soc Nephrol 7: 871-876
12. 2 microglobulin during hemodialysis using polysulfone, polyacrylonitrile, polymethyl-methacrylate and cuprammonium rayon membranes. Int J Artificial Organs 12: 692-702
13. Kunas GA, Burke RA, Brierton MA, Ofsthun NJ 1996 The effect of blod contact and reuse on the transport properties of high flux dialysis membranes. ASAIO Journal 42: 288-294
14. Lundberg L, Johansson G, Karlsson L, Stegmayer BG 1994 Complement activation is influenced by membrane material, design of the dialyser, sterilizing method and type of dialysate. Nephrol Dial Transplant 9: 1310-1314
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
16. Matthews JNS, Hoenich NA 1994 Clinical comparison of high flux cellulose acetate and synthetic membranes Nephrol. Dial Transpl 9: 60-66
17. Okada M, Takesawa S, Watanabe T, Imamura K, Tsurumi T, Suma Y, Sakai K 1989 Effects of zeta potential on the permeability of dialysis membranes to inorganic phosphate. ASAIO Transactions 35: 320-322
18. Pekna M, Hagman L, Halden E, Nilsson UR, Nilsson B, Thelin S 1994 Complement activation during cardiopulmonary bypass: Effects of immobilized heparin. Ann Thorac Surg 58: 421-424
19. Pertosa G, Tarantino EA, Gesualdo L, Montinaro V, Schena FP 1993 C5b-9 generation and cytokine production in hemodialyzed patients. Kidney International 43 (Suppl 41): S221-S225
20. Radovich JM 1995 Composition of polymer membranes for therapie of end stage renal disease. In: Bonomini V, Berland Y (eds). Dialysis membranes: Structures and predictions. Contributions to Nephrology. Krager, Basel 113: 11-24
21. Svensmark O 1958 Determination of protein in cerebrospinal fluid. A comment on the Lowry method. Scand J Clin Lab Invest 10: 50-52
22. Takesawa S, Ohmi S, Konno Y, Sekigutchi M et al. 1987 Varying methods of sterilisation and their effects on the structure and permeability of dialysis membranes. Nephrol Dial Transpl 1: 254-257
23. 2 microglobulin removal is possible with low flux membranes. J Amer Soc Nephrol 6: 505
24. Woffindin C, Hoenich NA, Matthews JNS 1992 Cellulose based haemodialysis membranes: Biocompatibility and functional performance compared. Nephrol Dial Transpl 7: 340-345